{
  "id": 16710797,
  "title": "M42 and 10XREVIV plan GLP-1 nutrition clinical study",
  "url": "https://urgent.news/2026/10/27/m42-and-10xreviv-plan-glp-1-nutrition-clinical-study",
  "topic": "world",
  "section": "World",
  "published": "2026-10-27T04:13:02.000Z",
  "source": {
    "name": "Arabian Post",
    "slug": "arabian-post",
    "url": "https://thearabianpost.com/m42-and-10xreviv-plan-glp-1-nutrition-clinical-study/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Arabian Post Staff -Dubai Abu Dhabi-based M42 research subsidiary IROS and 10XREVIV have announced a clinical study to test whether personalised nutrition can improve health outcomes for patients taking GLP-1 medicines for weight management. The planned research will compare 10XREVIV’s precision nutrition system combined with standard medical care against standard care alone, examining whether…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}